Literature DB >> 2991578

Monocyte-derived inhibitor of interleukin 1 induced by human cytomegalovirus.

B C Rodgers, D M Scott, J Mundin, J G Sissons.   

Abstract

It has previously been shown that human cytomegalovirus (HCMV) can exert immunosuppressive effects, and it has been suggested that these may be mediated by monocytes, although the mechanism is unclear. We showed that infection of human monocytes with the AD169 strain of HCMV abrogates their production of interleukin 1 (IL-1) activity. This was associated with the release from infected monocytes of an inhibitor of IL-1 activity which was also released after HCMV infection of the U937 macrophage-like cell line. The inhibitor of IL-1 activity is a protein with an apparent molecular weight of ca. 95,000. This action of HCMV strain AD169 was virus specific and required infectious virus but occurred without virus replication or detectable expression of viral proteins. This effect may account, at least in part, for the previously observed immunosuppressive properties of HCMV.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991578      PMCID: PMC254999     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  In vitro activation of a human macrophage-like cell line.

Authors:  H S Koren; S J Anderson; J W Larrick
Journal:  Nature       Date:  1979-05-24       Impact factor: 49.962

2.  Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions.

Authors:  W P Carney; M S Hirsch
Journal:  J Infect Dis       Date:  1981-07       Impact factor: 5.226

3.  Mechanisms of immunosuppression in cytomegaloviral mononucleosis.

Authors:  C R Rinaldo; W P Carney; B S Richter; P H Black; M S Hirsch
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

4.  Potentiation of cultured mouse thymocyte responses by factors released by peripheral leucocytes.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

5.  Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia.

Authors:  L C Goldstein; J McDougall; R Hackman; J D Meyers; E D Thomas; R C Nowinski
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

6.  Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation.

Authors:  R T Schooley; M S Hirsch; R B Colvin; A B Cosimi; N E Tolkoff-Rubin; R T McCluskey; R C Burton; P S Russell; J T Herrin; F L Delmonico; J V Giorgi; W Henle; R H Rubin
Journal:  N Engl J Med       Date:  1983-02-10       Impact factor: 91.245

7.  Cryopreserved human cultured T cells as responder cells for the quantitative measurement of interleukin-2: improvement of the assay.

Authors:  M Gramatzki; D M Strong; S B Grove; G D Bonnard
Journal:  J Immunol Methods       Date:  1982-09-17       Impact factor: 2.303

8.  Expression of recombinant genes containing herpes simplex virus delayed-early and immediate-early regulatory regions and trans activation by herpesvirus infection.

Authors:  P O'Hare; G S Hayward
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

9.  Identification of a specific interleukin 1 inhibitor in the urine of febrile patients.

Authors:  Z Liao; R S Grimshaw; D L Rosenstreich
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

10.  Characterization of the herpes simplex virion-associated factor responsible for the induction of alpha genes.

Authors:  W Batterson; B Roizman
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

View more
  23 in total

1.  Characterization of a murine cytomegalovirus-induced immunosuppressive factor.

Authors:  P F Whyte; R Subramaniam; J B Hudson
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

2.  Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies.

Authors:  M Lotz; C D Tsoukas; C A Robinson; C A Dinarello; D A Carson; J H Vaughan
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

3.  Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays.

Authors:  H Zhu; J P Cong; G Mamtora; T Gingeras; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

4.  Lymphocytic choriomeningitis virus-induced immunodepression: inherent defect of B and T lymphocytes.

Authors:  M F Saron; B Shidani; M A Nahori; J C Guillon; P Truffa-Bachi
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

Review 5.  Molecular biology and immunology of cytomegalovirus.

Authors:  P D Griffiths; J E Grundy
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

6.  Cytomegalovirus infection of peripheral blood mononuclear cells: effects on interleukin-1 and -2 production and responsiveness.

Authors:  K Kapasi; G P Rice
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

Review 7.  The status of CMV as a human pathogen.

Authors:  P D Griffiths; J E Grundy
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

8.  Inhibition of antibody-dependent cell-mediated cytolysis of tumor cells by Fc receptor of human cytomegalovirus. Brief report.

Authors:  T Murayama; K Shimokawa; T Furukawa
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

9.  Interleukin-1 production in acute viral hepatitis.

Authors:  C Müller; I Gödl; R Ahmad; H M Wolf; J W Mannhalter; M M Eibl
Journal:  Arch Dis Child       Date:  1989-02       Impact factor: 3.791

10.  Replication of human cytomegalovirus in the cells of the U937 monocytoid cell line.

Authors:  K Numazaki; N Nagata; T Sato; S Chiba
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.